Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Fins deadline sept 29

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Sep 29, 2021 12:01pm

105 Views

Post# 33937111

RE:Fins deadline sept 29

filing last minute as usual.

lscfa wrote:

Jump in revenues?

Qtr ending

Revenue

Jul 21

?

Apr 21

190,923

Jan 21

18,159

Oct 20

105,711

Jul 20

Apr 20

Jan 20

Oct 19

71,243